REQUEST A DEMO
Total
USD $0.00
Search more companies

Genome-Molecule Laboratory Company Limited (Thailand)

Main Activities: Research and Development in Nanotechnology
Full name: Genome-Molecule Laboratory Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Genome-Molecule Laboratory Company Limited is a company in Thailand, with a head office in Bangkok , Special Governed District of. It operates in the Research and Development in Nanotechnology industry. It was first established on May 22, 2026. It currently has a total number of 29 (2024) employees. In 2024, the company reported a net sales revenue increase of 11.17%. Its’ total assets recorded a growth of 2.91%. The net profit margin of Genome-Molecule Laboratory Company Limited decreased by 1.42% in 2024.

Headquarters
61 Sena Nikhom 1 Road Soi Sena Nikhom 1 Soi 42
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10230

Contact Details: Purchase the Genome-Molecule Laboratory Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Genome-Molecule Laboratory Company Limited report to view the information.
Financial Auditors:
Purchase the Genome-Molecule Laboratory Company Limited report to view the information.
Incorporation Date:
May 22, 2026
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Genome-Molecule Laboratory Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
11.17%
Total Operating Revenue
11.24%
Operating Profit
-49.09%
EBITDA
-49.09%
Net Profit/Loss for the Period
-62.95%
Total Assets
2.91%
Total Equity
1.59%
Operating Profit Margin
-1.66%
Net Profit Margin
-1.42%
Return on Equity (ROE)
-2.73%
Debt / Equity
3.55%
Quick Ratio
-0.02%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?